GAD1

gene product
GAD
This gene encodes one of several forms of glutamic acid decarboxylase, identified as a major autoantigen in insulin-dependent diabetes. The enzyme encoded is responsible for catalyzing the production of gamma-aminobutyric acid from L-glutamic acid. A pathogenic role for this enzyme has been identified in the human pancreas since it has been identified as an autoantigen and an autoreactive T cell target in insulin-dependent diabetes. This gene may also play a role in the stiff man syndrome. Deficiency in this enzyme has been shown to lead to pyridoxine dependency with seizures. Alternative splicing of this gene results in two products, the predominant 67-kD form and a less-frequent 25-kD form. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
350 antibodies from 29 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
GeneTex
11 antibodies
Novus Biologicals
21 antibodies
OriGene
3 antibodies
Aviva Systems Biology
7 antibodies
antibodies-online
129 antibodies
Acris Antibodies GmbH
14 antibodies
Biorbyt
29 antibodies
Thermo Fisher Scientific Pierce
7 antibodies
R&D Systems
3 antibodies
Abnova Corporation
11 antibodies
Bioworld Technology, Inc
2 antibodies
Atlas Antibodies
1 antibody
Santa Cruz Biotechnology
1 antibody
Signalway Antibody LLC
2 antibodies
Everest Biotech
2 antibodies
Creative Biomart
27 antibodies
RabMAbs
3 antibodies
Abgent
2 antibodies
Abbiotec
1 antibody
LifeSpan BioSciences, Inc.
36 antibodies
Spring Bioscience
4 antibodies
RayBiotech, Inc.
3 antibodies
BosterBio
2 antibodies
Cell Signaling Technology, Inc
1 antibody
GenWay
1 antibody
United States Biological
10 antibodies
EMD Millipore
2 antibodies
Sigma-Aldrich
3 antibodies